| Ramona Selena Colas, CNM | |
|
6617 Fm 2920 Rd Ste 200, Spring, TX 77379-2636 | |
| (281) 206-4496 | |
| (281) 206-4487 |
| Full Name | Ramona Selena Colas |
|---|---|
| Gender | Female |
| Speciality | Advanced Practice Midwife |
| Location | 6617 Fm 2920 Rd Ste 200, Spring, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861425639 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | AP110725 (Texas) | Primary |
| Entity Name | Chca Bayshore Lp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518941236 PECOS PAC ID: 3173437753 Enrollment ID: O20100629000184 |
News Archive
The thalamus is the central translator in the brain: Specialized nerve cells (neurons) receive information from the sensory organs, process it, and transmit it deep into the brain. Researchers from the Institute of Toxicology and Genetics (ITG) of KIT have now identified the genetic factors Lhx2 and Lhx9 responsible for the development of these neurons.
BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive, disposable drug-free anti-inflammatory devices, today announces its schedule for filing with the U.S. government's Food and Drug Administration for 510(K) pre-marketing clearance for its ActiPatch® Therapy and RecoveryRx™ products. In these applications BioElectronics will seek over-the-counter clearance of its ActiPatch Therapy product for indications for the treatment of heel and foot pain, and for pain relief relative to general musculoskeletal complaints.
Yissum Research Development Company Ltd., the technology transfer company of the Hebrew University of Jerusalem, and Hadasit Medical Research Services & Development Ltd., the technology transfer company of the Hadassah University Medical Center, today announced that they have licensed innovative regenerative membrane implant technology to RegeneCure, which will further develop and commercialize the technology for bone tissue engineering for applications in trauma, spine, and reconstructive cranial and facial orthopedics.
Metamark Genetics, Inc., a privately-held oncology-focused molecular diagnostics company, today announced results from a melanoma study published in Cancer Cell.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ramona Selena Colas, CNM 13523 Hargrave Rd, Houston, TX 77070-3829 Ph: (281) 206-4496 | Ramona Selena Colas, CNM 6617 Fm 2920 Rd Ste 200, Spring, TX 77379-2636 Ph: (281) 206-4496 |
News Archive
The thalamus is the central translator in the brain: Specialized nerve cells (neurons) receive information from the sensory organs, process it, and transmit it deep into the brain. Researchers from the Institute of Toxicology and Genetics (ITG) of KIT have now identified the genetic factors Lhx2 and Lhx9 responsible for the development of these neurons.
BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive, disposable drug-free anti-inflammatory devices, today announces its schedule for filing with the U.S. government's Food and Drug Administration for 510(K) pre-marketing clearance for its ActiPatch® Therapy and RecoveryRx™ products. In these applications BioElectronics will seek over-the-counter clearance of its ActiPatch Therapy product for indications for the treatment of heel and foot pain, and for pain relief relative to general musculoskeletal complaints.
Yissum Research Development Company Ltd., the technology transfer company of the Hebrew University of Jerusalem, and Hadasit Medical Research Services & Development Ltd., the technology transfer company of the Hadassah University Medical Center, today announced that they have licensed innovative regenerative membrane implant technology to RegeneCure, which will further develop and commercialize the technology for bone tissue engineering for applications in trauma, spine, and reconstructive cranial and facial orthopedics.
Metamark Genetics, Inc., a privately-held oncology-focused molecular diagnostics company, today announced results from a melanoma study published in Cancer Cell.
› Verified 3 days ago
Chantel Latresa Ashley, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 8714 Spring Cypress Rd, Suite 200, Spring, TX 77379 Phone: 281-251-6394 | |
Shanna Lynn Willis, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 419 Gentry St, Spring, TX 77373 Phone: 281-296-0343 Fax: 281-503-7765 | |
Diana D Matlack, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 2495 Sawdust Rd Apt 1101, Spring, TX 77380 Phone: 315-216-6625 | |
Jaelin Stickels, Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 26614 Oak Ridge Dr, Spring, TX 77380 Phone: 281-296-2333 |